Medicure Inc. (MPH.V)
CAD 0.9
(0.0%)
CAD 0.9
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 229 Thousand CAD | -54.47% |
| 2022 | 503 Thousand CAD | -36.25% |
| 2021 | 789 Thousand CAD | -26.94% |
| 2020 | 1.08 Million CAD | 27.21% |
| 2019 | 849 Thousand CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | -100.0% |
| 2016 | 68.42 Million CAD | 2513.96% |
| 2015 | 2.61 Million CAD | -38.06% |
| 2014 | 4.22 Million CAD | 0.0% |
| 2012 | 3.51 Million CAD | -24.48% |
| 2011 | 4.64 Million CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | -100.0% |
| 2008 | 25.04 Million CAD | -22.23% |
| 2007 | 32.2 Million CAD | 198.67% |
| 2006 | 10.78 Million CAD | 0.0% |
| 2005 | - CAD | 0.0% |
| 2004 | - CAD | 0.0% |
| 2003 | - CAD | 0.0% |
| 2002 | - CAD | 0.0% |
| 2001 | - CAD | 0.0% |
| 2000 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 210 Thousand CAD | 0.0% |
| 2024 Q2 | 187 Thousand CAD | 0.0% |
| 2023 Q4 | 229 Thousand CAD | -16.73% |
| 2023 Q2 | 345 Thousand CAD | -19.2% |
| 2023 FY | 229 Thousand CAD | -54.47% |
| 2023 Q3 | 275 Thousand CAD | -20.29% |
| 2023 Q1 | 427 Thousand CAD | -15.11% |
| 2022 Q3 | 599 Thousand CAD | -6.41% |
| 2022 Q4 | 503 Thousand CAD | -16.03% |
| 2022 FY | 503 Thousand CAD | -36.25% |
| 2022 Q1 | 714 Thousand CAD | -9.51% |
| 2022 Q2 | 640 Thousand CAD | -10.36% |
| 2021 Q3 | 868 Thousand CAD | -6.47% |
| 2021 Q1 | 1 Million CAD | -6.85% |
| 2021 Q4 | 789 Thousand CAD | -9.1% |
| 2021 FY | 789 Thousand CAD | -26.94% |
| 2021 Q2 | 928 Thousand CAD | -7.75% |
| 2020 Q2 | 738 Thousand CAD | -6.94% |
| 2020 FY | 1.08 Million CAD | 27.21% |
| 2020 Q3 | 684 Thousand CAD | -7.32% |
| 2020 Q1 | 793 Thousand CAD | -6.6% |
| 2020 Q4 | 1.08 Million CAD | 57.89% |
| 2019 FY | 849 Thousand CAD | 0.0% |
| 2019 Q2 | 233 Thousand CAD | -23.61% |
| 2019 Q3 | 162 Thousand CAD | -30.47% |
| 2019 Q1 | 305 Thousand CAD | 0.0% |
| 2019 Q4 | 849 Thousand CAD | 424.07% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2017 FY | - CAD | -100.0% |
| 2017 Q4 | - CAD | -100.0% |
| 2017 Q3 | 55.81 Million CAD | -1.46% |
| 2017 Q2 | 56.64 Million CAD | 0.3% |
| 2017 Q1 | 56.47 Million CAD | -17.47% |
| 2016 FY | 68.42 Million CAD | 2513.96% |
| 2016 Q2 | 1.79 Million CAD | -18.63% |
| 2016 Q1 | 2.2 Million CAD | -15.72% |
| 2016 Q3 | 1.38 Million CAD | -22.96% |
| 2016 Q4 | 68.42 Million CAD | 4848.06% |
| 2015 Q4 | 2.61 Million CAD | -13.36% |
| 2015 Q1 | 3.83 Million CAD | 0.0% |
| 2015 Q3 | 3.02 Million CAD | -11.95% |
| 2015 FY | 2.61 Million CAD | -38.06% |
| 2015 Q2 | 3.43 Million CAD | -10.58% |
| 2014 FY | 4.22 Million CAD | 0.0% |
| 2014 Q1 | 4.83 Million CAD | 0.3% |
| 2014 Q2 | 4.84 Million CAD | 0.34% |
| 2014 Q3 | 4.72 Million CAD | -2.56% |
| 2013 Q1 | 3.9 Million CAD | -19.46% |
| 2013 Q2 | 3.51 Million CAD | -10.08% |
| 2013 Q3 | 4.8 Million CAD | 36.83% |
| 2013 Q4 | 4.81 Million CAD | 0.28% |
| 2012 Q2 | 4.64 Million CAD | 0.66% |
| 2012 FY | 3.51 Million CAD | -24.48% |
| 2012 Q4 | 4.84 Million CAD | -7.19% |
| 2012 Q3 | 5.22 Million CAD | 12.37% |
| 2012 Q1 | 4.61 Million CAD | 0.77% |
| 2011 FY | 4.64 Million CAD | 0.0% |
| 2011 Q4 | 4.58 Million CAD | -13.96% |
| 2011 Q3 | 5.32 Million CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2010 Q1 | 24.24 Million CAD | -0.27% |
| 2010 Q2 | - CAD | -100.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2009 Q1 | 29.36 Million CAD | 3.17% |
| 2009 Q3 | 25.17 Million CAD | 0.52% |
| 2009 Q2 | 25.04 Million CAD | -14.71% |
| 2009 Q4 | 24.31 Million CAD | -3.42% |
| 2009 FY | - CAD | -100.0% |
| 2008 Q4 | 28.45 Million CAD | -17.85% |
| 2008 Q3 | 34.64 Million CAD | 7.58% |
| 2008 Q2 | 32.2 Million CAD | 1.18% |
| 2008 Q1 | 31.82 Million CAD | -7.22% |
| 2008 FY | 25.04 Million CAD | -22.23% |
| 2007 Q3 | 12.38 Million CAD | 14.88% |
| 2007 Q1 | 13.47 Million CAD | -8.96% |
| 2007 FY | 32.2 Million CAD | 198.67% |
| 2007 Q4 | 34.3 Million CAD | 176.93% |
| 2007 Q2 | 10.78 Million CAD | -19.99% |
| 2006 Q1 | - CAD | 0.0% |
| 2006 Q4 | 14.8 Million CAD | -7.0% |
| 2006 Q2 | - CAD | 0.0% |
| 2006 FY | 10.78 Million CAD | 0.0% |
| 2006 Q3 | 15.91 Million CAD | 0.0% |
| 2005 FY | - CAD | 0.0% |
| 2005 Q3 | - CAD | 0.0% |
| 2005 Q1 | - CAD | 0.0% |
| 2005 Q2 | - CAD | 0.0% |
| 2005 Q4 | - CAD | 0.0% |
| 2004 Q3 | - CAD | 0.0% |
| 2004 Q2 | - CAD | 0.0% |
| 2004 FY | - CAD | 0.0% |
| 2004 Q1 | - CAD | 0.0% |
| 2004 Q4 | - CAD | 0.0% |
| 2003 Q2 | - CAD | 0.0% |
| 2003 Q1 | - CAD | 0.0% |
| 2003 FY | - CAD | 0.0% |
| 2003 Q3 | - CAD | 0.0% |
| 2003 Q4 | - CAD | 0.0% |
| 2002 FY | - CAD | 0.0% |
| 2002 Q4 | - CAD | 0.0% |
| 2002 Q3 | - CAD | 0.0% |
| 2001 FY | - CAD | 0.0% |
| 2000 FY | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 583.58 Thousand CAD | 60.76% |
| CanadaBis Capital Inc. | 5.91 Million CAD | 96.129% |
| Decibel Cannabis Company Inc. | 32.34 Million CAD | 99.292% |
| Delivra Health Brands Inc. | 1.78 Million CAD | 87.171% |
| Entourage Health Corp. | 5.79 Million CAD | 96.047% |
| Lifeist Wellness Inc. | 868.65 Thousand CAD | 73.637% |
| Cannara Biotech Inc. | 39.73 Million CAD | 99.424% |
| PharmaCielo Ltd. | 2.55 Million CAD | 91.032% |
| Rubicon Organics Inc. | - CAD | -Infinity% |
| BioSyent Inc. | 1.03 Million CAD | 77.933% |
| Voyageur Pharmaceuticals Ltd. | 40 Thousand CAD | -472.5% |